Need professional-grade analysis? Visit stockanalysis.com
$37.06B
18.36
7,220
522.00%
Chongqing Zhifei Bio Products (300122) trades on SHE in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY15.47, down 1.40% from the previous close.
Over the past year, 300122 has traded between a low of CNY14.78 and a high of CNY25.06. The stock has lost 23.5% over this period. It is currently 38.3% below its 52-week high.
Chongqing Zhifei Bio Products has a market capitalization of $37.06B, with a price-to-earnings ratio of 18.36 and a dividend yield of 522.00%.
Chongqing Zhifei Biological Products Co., Ltd. engages in the research and development, production, marketing, distribution, import, and export of vaccines in China. The company offers Recombinant Novel Coronavirus Vaccine (CHO Cell); Recombinant Mycobacterium Tuberculosis Fusion Protein under the Ekear brand; Haemophilus Influenzae Type b Vaccine under the XiFeiBei brand; ACYW135 Meningococcal Polysaccharide Vaccine under the Menwayc brand; Mycobacterium Vaccae for Injection under the Vaccae brand; Meningococcal Group A and Group C Polysaccharide Conjugate Vaccine under the Mening A Con brand; and other developed products. It also provides cold storage services. Chongqing Zhifei Biological Products Co., Ltd. was founded in 2002 and is based in Chongqing, China.
Side-by-side comparison against top Healthcare peers.